Cargando…

Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro

BACKGROUND: This study was aimed at identifying prognostic biomarkers for stage II-IIIA non-small cell lung cancer (NSCLC) according to histology and at investigating the effect of vorinostat on the expression of these biomarkers. METHODS: Expression levels of cyclin D1, cyclin A2, cyclin E, and p16...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Eunju, Jin, DongHao, Lee, Bo Bin, Kim, Yujin, Han, Joungho, Shim, Young Mog, Kim, Duk-Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4683946/ https://www.ncbi.nlm.nih.gov/pubmed/26681199 http://dx.doi.org/10.1186/s12885-015-2001-7

Ejemplares similares

RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung
por: Kim, Yujin, et al.
Publicado: (2015)

Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer
por: Kim, Dohun, et al.
Publicado: (2020)

Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells
por: Lee, Bo Bin, et al.
Publicado: (2023)

Aberrant Methylation of SLIT2 Gene in Plasma Cell-Free DNA of Non-Small Cell Lung Cancer Patients
por: Kim, Yujin, et al.
Publicado: (2022)

Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells
por: Kim, Dongho, et al.
Publicado: (2021)

Metformin induces cell cycle arrest at the G1 phase through E2F8 suppression in lung cancer cells
por: Jin, Dong Hao, et al.
Publicado: (2017)

Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer
por: Kim, Yujin, et al.
Publicado: (2020)

Metformin and tenovin‐6 synergistically induces apoptosis through LKB1‐independent SIRT1 down‐regulation in non‐small cell lung cancer cells
por: Lee, Bo Bin, et al.
Publicado: (2019)

Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer
por: Um, Sang-Won, et al.
Publicado: (2017)

Genome-wide analysis of DNA methylation in bronchial washings
por: Um, Sang-Won, et al.
Publicado: (2018)

Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1
por: Hwang, Su Jin, et al.
Publicado: (2015)

A Rare Case of Tumor-to-Tumor Metastasis of Thyroid Papillary Carcinoma within a Pulmonary Adenocarcinoma
por: Lee, Taebum, et al.
Publicado: (2015)

Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
por: Kang, Dong Woo, et al.
Publicado: (2020)

Epigenetic Inactivation of Heparan Sulfate (Glucosamine) 3-O-Sulfotransferase 2 in Lung Cancer and Its Role in Tumorigenesis
por: Hwang, Jung-Ah, et al.
Publicado: (2013)

HOXA11 hypermethylation is associated with progression of non-small cell lung cancer
por: Hwang, Jung-Ah, et al.
Publicado: (2013)

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.
por: Shin, K. Y., et al.
Publicado: (1997)

Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma
por: Yoon, Mee Sun, et al.
Publicado: (2016)

Vorinostat—An Overview
por: Bubna, Aditya Kumar
Publicado: (2015)

Quantitative CT Analysis of Pulmonary Ground-Glass Opacity Nodules for the Distinction of Invasive Adenocarcinoma from Pre-Invasive or Minimally Invasive Adenocarcinoma
por: Son, Ji Ye, et al.
Publicado: (2014)

Preoperative Concurrent Radiochemotherapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer
por: Kang, Min Kyu, et al.
Publicado: (2006)

Genomic alterations of ground-glass nodular lung adenocarcinoma
por: Lee, Hyun, et al.
Publicado: (2018)

Clinical Efficacy of Vorinostat in a Patient with Leiomyosarcoma
por: Lee, Jin, et al.
Publicado: (2012)

Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2015)

A Rare Case of Mixed Type A Thymoma and Micronodular Thymoma with Lymphoid Stroma
por: Cha, Yoon Jin, et al.
Publicado: (2015)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

Local Delivery of Minocycline and Vorinostat Targets the Tumor Microenvironment to Inhibit the Recurrence of Glioma
por: Zhao, Gang, et al.
Publicado: (2020)

Differential Response of Mycosis Fungoides Cells to Vorinostat
por: Bordeaux, Zachary A., et al.
Publicado: (2023)

Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation
por: Bergadà, Laura, et al.
Publicado: (2014)

An Unusual Case of Pulmonary Mucous Gland Adenoma with Fibromyxoid Stroma and Cartilage Islands in 68-Year-Old Woman
por: Lee, Boram, et al.
Publicado: (2014)

Exuberant Vasculoconnective Component in Mediastinal Mixed Germ Cell Tumors
por: Cha, Yoon Jin, et al.
Publicado: (2015)

Size and extranodal extension of metastatic lymph nodes in lung adenocarcinoma
por: Moon, Duk Hwan, et al.
Publicado: (2020)

Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2017)

Vorinostat (SAHA) and Breast Cancer: An Overview
por: Wawruszak, Anna, et al.
Publicado: (2021)

Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma
por: Kim, Wooil, et al.
Publicado: (2016)

Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells
por: Kwak, Tae Won, et al.
Publicado: (2013)

Evaluating the tumor biology of lung adenocarcinoma: A multimodal analysis
por: Kim, Ki Hwan, et al.
Publicado: (2019)

A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
por: Goncalves, Priscila H., et al.
Publicado: (2017)

The Effect of Vorinostat on the Development of Resistance to Doxorubicin in Neuroblastoma
por: Lautz, Timothy B., et al.
Publicado: (2012)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

Ultrasonographic findings of type IIIa biliary atresia
por: Kim, Seung-seob, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bk2m19jt3ura0qoiv457l2aadb